These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 19241402)
1. New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Birlea SA; Costin GE; Norris DA Med Res Rev; 2009 May; 29(3):514-46. PubMed ID: 19241402 [TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Birlea SA; Costin GE; Norris DA Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827 [TBL] [Abstract][Full Text] [Related]
3. The role of vitamin D in melanogenesis with an emphasis on vitiligo. AlGhamdi K; Kumar A; Moussa N Indian J Dermatol Venereol Leprol; 2013; 79(6):750-8. PubMed ID: 24177606 [TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model. Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389 [TBL] [Abstract][Full Text] [Related]
5. Topical treatment and combination approaches for vitiligo: new insights, new developments. Hossani-Madani AR; Halder RM G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746 [TBL] [Abstract][Full Text] [Related]
6. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Saraceno R; Nisticò SP; Capriotti E; Chimenti S Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584 [TBL] [Abstract][Full Text] [Related]
7. Low-energy helium-neon laser induces melanocyte proliferation via interaction with type IV collagen: visible light as a therapeutic option for vitiligo. Lan CC; Wu CS; Chiou MH; Chiang TY; Yu HS Br J Dermatol; 2009 Aug; 161(2):273-80. PubMed ID: 19438447 [TBL] [Abstract][Full Text] [Related]
8. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111 [TBL] [Abstract][Full Text] [Related]
9. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. Dogra S; Kumar B Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926 [TBL] [Abstract][Full Text] [Related]
10. Vitiligo treatment in childhood: a state of the art review. Tamesis ME; Morelli JG Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403 [TBL] [Abstract][Full Text] [Related]
11. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study. Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo. Yu S; Lan CE; Yu HS Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884 [TBL] [Abstract][Full Text] [Related]
13. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133 [TBL] [Abstract][Full Text] [Related]
14. Current remedies for vitiligo. Abu Tahir M; Pramod K; Ansari SH; Ali J Autoimmun Rev; 2010 May; 9(7):516-20. PubMed ID: 20149899 [TBL] [Abstract][Full Text] [Related]
15. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Birlea SA; Costin GE; Roop DR; Norris DA Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168 [TBL] [Abstract][Full Text] [Related]